Last reviewed · How we verify
Non-active base from azelaic acid 15% gel — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Non-active base from azelaic acid 15% gel (Non-active base from azelaic acid 15% gel) — LEO Pharma.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Non-active base from azelaic acid 15% gel TARGET | Non-active base from azelaic acid 15% gel | LEO Pharma | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Non-active base from azelaic acid 15% gel CI watch — RSS
- Non-active base from azelaic acid 15% gel CI watch — Atom
- Non-active base from azelaic acid 15% gel CI watch — JSON
- Non-active base from azelaic acid 15% gel alone — RSS
Cite this brief
Drug Landscape (2026). Non-active base from azelaic acid 15% gel — Competitive Intelligence Brief. https://druglandscape.com/ci/non-active-base-from-azelaic-acid-15-gel. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab